Table 4.
Characteristics | All yearsa | 2010b | 2020c | P-interactiond |
OR (95% CI) | OR (95% CI) | OR (95% CI) | ||
Patient-related | ||||
Age | ||||
<50 yr | Reference | Reference | Reference | 0.30 |
50–75 yr | 0.82 (0.77–0.88) | 1.69 (0.58–4.93) | 0.75 (0.64–0.86) | |
>75 yr | 0.80 (0.73–0.88) | 1.84 (0.22–15.40) | 0.54 (0.44–0.66) | |
Sex | ||||
Male | Reference | Reference | Reference | 0.41 |
Female | 1.21 (1.17–1.26) | 0.99 (0.68–1.44) | 1.16 (1.04–1.29) | |
BMI | ||||
<25 kg/m2 | Reference | Reference | Reference | 0.98 |
25–30 kg/m2 | 1.04 (0.98–1.10) | 0.99 (0.42–2.35) | 0.92 (0.80–1.05) | |
>30 kg/m2 | 0.99 (0.91–1.08) | 0.97 (0.43–2.19) | 0.93 (0.77–1.11) | |
Unknown | 1.49 (1.33–1.66) | 2.41 (1.39–4.17) | 0.93 (0.78–1.11) | |
Race | ||||
White | Reference | Reference | Reference | 0.88 |
Asian | 0.59 (0.54–0.65) | 0.63 (0.39–1.00) | 0.57 (0.48–0.68) | |
African American | 0.43 (0.36–0.51) | 0.41 (0.06–3.06) | 0.38 (0.22–0.65) | |
Other | 0.57 (0.49–0.66) | 0.42 (0.09–1.90) | 0.62 (0.52–0.75) | |
Unknown | 0.74 (0.67–0.81) | 0.47 (0.15–1.46) | 0.74 (0.59–0.92) | |
Smoking status | ||||
Never smoker | Reference | Reference | Reference | 0.40 |
Current smoker | 1.06 (0.97–1.15) | 0.58 (0.11–3.10) | 1.19 (0.92–1.54) | |
Former smoker | 0.95 (0.89–1.00) | 1.02 (0.52–2.01) | 0.92 (0.80–1.05) | |
Unknown | 0.94 (0.87–1.01) | 0.40 (0.27–0.58) | 1.10 (0.95–1.28) | |
Charlson comorbidity | ||||
0 | Reference | Reference | Reference | 0.13 |
1 | 0.92 (0.88–0.95) | 1.34 (0.74–2.40) | 0.76 (0.67–0.87) | |
≥2 | 0.85 (0.82–0.88) | 1.26 (0.70–2.26) | 0.80 (0.70–0.91) | |
Colonoscopy indication | ||||
Average risk | Reference | Reference | Reference | 0.18 |
High risk | 0.90 (0.85–0.96) | 1.63 (0.75–3.51) | 0.96 (0.88–1.05) | |
Procedure-related | ||||
Mucosal assist device | ||||
No | Reference | Reference | Reference | NAe |
Yes | 1.11 (0.95–1.29) | NAe | 1.07 (0.88–1.29) | |
High-definition colonoscope | ||||
No | Reference | Reference | Reference | NAf |
Yes | 1.33 (1.17–1.50) | NAf | 1.13 (0.79–1.61) | |
Unknown | 2.01 (1.68–2.41) | 0.87 (0.23–3.21) | 1.00 (0.58–1.73) | |
Withdrawal time | ||||
<6 min | Reference | Reference | Reference | 0.55 |
6–9 min | 1.38 (0.83–2.32) | 0.31 (0.05–1.83) | 1.57 (0.54–4.53) | |
>9 min | 4.56 (2.57–8.12) | 1.11 (0.48–2.54) | 4.43 (1.26–15.59) | |
Missing | 3.80 (2.11–6.85) | NA | 2.45 (0.66–9.13) | |
Preparation quality | ||||
Adequate (excellent, good, or fair) | Reference | Reference | Reference | 0.03 |
Inadequate (poor) | 0.79 (0.53–1.18) | 3.16 (0.92–10.80) | 0.40 (0.14–1.19) | |
Sedation type | ||||
Moderate sedation | Reference | Reference | Reference | 0.75 |
Other | 0.90 (0.82–0.99) | 0.83 (0.37–1.84) | 0.95 (0.81–1.12) | |
Physician-related | ||||
Endoscopist sex | ||||
Male physician | Reference | Reference | Reference | 0.01 |
Female physician | 1.11 (0.89–1.39) | 2.54 (1.21–5.33) | 0.86 (0.64–1.16) | |
Years in practice | ||||
<11 yr | Reference | Reference | Reference | 0.002 |
11–25 yr | 0.89 (0.71–1.13) | 4.36 (1.37–13.89) | 0.99 (0.77–1.27) | |
>25 yr | 0.57 (0.30–1.08) | 1.34 (0.31–5.86) | 0.99 (0.82–1.20) |
BMI, body mass index; CI, confidence interval; OR, odds ratio; SSADR, sessile serrated adenoma detection rate.
Multivariate model included variables for all patient-related, procedure-related, and physician-related characteristics and fixed effects of each year from 2010 to 2020.
Multivariate model in variables for all patient-related, procedure-related, and physician-related characteristics, except for mucosal assist device and high-definition colonoscope.
Multivariate model in variables for all patient-related, procedure-related, and physician-related characteristics.
P-interaction was calculated using cross product of year and with respective risk factor. Missing and unknown categories were omitted in the model to improve interpretability.
No mucosal assist device was used in 2010, so interaction was not calculated.
Interaction term was not calculated because OR did not converge for high-definition colonoscope in 2010.